Analyses of mRNA using RT-qPCR and microarray, along with Western Blot and immunohistochemistry, confirmed the increased expression of COX-2 in B lymphocytes purified from the peripheral blood of CLL patients (24). This evidence concerns the gene PTGS2 and B-cell chronic lymphocytic leukemia.